MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Graham Robinson
Graham RobinsonKirkland & Ellis

Graham Robinson

Partner at Kirkland & Ellis

Lawyer

Boston

Deal Bio

Total Deals74
Valued Deals70
Total Value£ 247.29 B
Avg. Deal Size£ 3.53 B

Market Context

Awards

2024 Top Healthcare Lawyers in North America
2023 Top Healthcare Lawyers in North America
2023 Top Advisor Lawyers in North America
 Show more

Sort

22 Jan 2018|United States|Biotechnology
Juno Therapeutics
Celgene Corporation

Target: JUNO THERAPEUTICS INC

Bidder: CELGENE CORPORATION

9 Service Providers

4 Target | 5 Bidder

60 Dealmakers

22 Target | 38 Bidder

£ 5.86 B

Value

28 Aug 2017|United States|Biotechnology
Kite Pharma
Gilead Sciences

Target: KITE PHARMA INC

Bidder: GILEAD SCIENCES

10 Service Providers

5 Target | 5 Bidder

24 Dealmakers

9 Target | 15 Bidder

£ 9.30 B

Value

08 Jan 2019|United States|Real Estate Holding and Development
Wework Companies
Softbank Group Corp

Target: WEWORK COMPANIES INC

Bidder: SOFTBANK GROUP CORP

4 Service Providers

2 Target | 2 Bidder

16 Dealmakers

7 Target | 9 Bidder

n/a

Value

07 Feb 2019|United States|Security Equipment
Webroot
Carbonite

Target: WEBROOT INC

Bidder: CARBONITE INC

12 Service Providers

4 Target | 8 Bidder

19 Dealmakers

4 Target | 15 Bidder

£ 477 M

Value

25 Feb 2019|Canada|Pharmaceuticals
Clementia Pharmaceuticals
IPSEN

Target: CLEMENTIA PHARMACEUTICALS

Bidder: IPSEN

9 Service Providers

4 Target | 5 Bidder

41 Dealmakers

14 Target | 27 Bidder

£ 995 M

Value

04 Mar 2019|United Kingdom|Biotechnology
Nightstar Therapeutics
Biogen

Target: NIGHTSTAR THERAPEUTICS

Bidder: BIOGEN INC

8 Service Providers

5 Target | 3 Bidder

30 Dealmakers

27 Target | 4 Bidder

£ 663 M

Value

17 Jun 2019|United States|Pharmaceuticals
Array Biopharma
Pfizer

Target: ARRAY BIOPHARMA

Bidder: PFIZER INC

10 Service Providers

4 Target | 6 Bidder

51 Dealmakers

21 Target | 30 Bidder

£ 9.05 B

Value

14 Jul 2019|Belgium|Biotechnology
Galapagos
Gilead Sciences

Target: GALAPAGOS NV

Bidder: GILEAD SCIENCES

15 Service Providers

7 Target | 8 Bidder

36 Dealmakers

24 Target | 12 Bidder

£ 849 M

Value

03 Sep 2019|United States|Pharmaceuticals
Semma Therapeutics
Vertex Pharmaceuticals

Target: SEMMA THERAPEUTICS

Bidder: VERTEX PHARMACEUTICALS INC

3 Service Providers

1 Target | 2 Bidder

26 Dealmakers

2 Target | 24 Bidder

£ 785 M

Value

16 Sep 2019|United States|Pharmaceuticals
Alder Biopharmaceuticals
Lundbeck As

Target: ALDER BIOPHARMACEUTICALS

Bidder: LUNDBECK AS

8 Service Providers

4 Target | 4 Bidder

10 Dealmakers

7 Target | 3 Bidder

£ 1.56 B

Value

22 Jan 2018|United States|Biotechnology
Bioverativ
Sanofi

Target: BIOVERATIV INC

Bidder: SANOFI SA

11 Service Providers

7 Target | 4 Bidder

45 Dealmakers

13 Target | 32 Bidder

£ 7.85 B

Value

16 Oct 2019|United States|Biotechnology
Achillion Pharmaceuticals
Alexion Pharmaceuticals

Target: ACHILLION PHARMACEUTICALS

Bidder: ALEXION PHARMACEUTICALS INC

6 Service Providers

4 Target | 2 Bidder

21 Dealmakers

17 Target | 4 Bidder

£ 732 M

Value

11 Nov 2019|United States|IT Services: Other
Carbonite
OPENTEXT

Target: CARBONITE INC

Bidder: OPENTEXT

10 Service Providers

7 Target | 3 Bidder

47 Dealmakers

18 Target | 29 Bidder

£ 1.11 B

Value

09 Dec 2019|United States|Biotechnology
Arqule
Merck Kgaa

Target: ARQULE INC

Bidder: MERCK KGAA

9 Service Providers

6 Target | 3 Bidder

62 Dealmakers

18 Target | 44 Bidder

£ 2.05 B

Value

22 Oct 2019|United States|Real Estate Holding and Development
Wework Companies
Softbank Group Corp

Target: WEWORK COMPANIES INC

Bidder: SOFTBANK GROUP CORP

14 Service Providers

7 Target | 7 Bidder

33 Dealmakers

24 Target | 9 Bidder

£ 3.47 B

Value

18 Feb 2020|United States|Asset Managers and Custodians
Legg Mason
Franklin Templeton Investments Corporation

Target: LEGG MASON INC

Bidder: FRANKLIN TEMPLETON INVESTMENTS CORPORATION

16 Service Providers

9 Target | 7 Bidder

63 Dealmakers

50 Target | 13 Bidder

£ 4.99 B

Value

02 Mar 2020|United States|Biotechnology
Forty Seven
Gilead Sciences

Target: FORTY SEVEN

Bidder: GILEAD SCIENCES

10 Service Providers

6 Target | 4 Bidder

48 Dealmakers

33 Target | 15 Bidder

£ 3.82 B

Value

04 May 2020|United States|Biotechnology
Stemline Therapeutics
Menarini Group

Target: STEMLINE THERAPEUTICS

Bidder: MENARINI GROUP

12 Service Providers

8 Target | 4 Bidder

44 Dealmakers

35 Target | 9 Bidder

£ 541 M

Value

05 May 2020|United States|Biotechnology
Portola Pharmaceuticals
Alexion Pharmaceuticals

Target: PORTOLA PHARMACEUTICALS

Bidder: ALEXION PHARMACEUTICALS INC

7 Service Providers

4 Target | 3 Bidder

50 Dealmakers

29 Target | 21 Bidder

£ 1.31 B

Value

19 Aug 2020|United States|Biotechnology
Momenta Pharmaceuticals
Johnson & Johnson

Target: MOMENTA PHARMACEUTICALS INC

Bidder: JOHNSON & JOHNSON

12 Service Providers

7 Target | 5 Bidder

57 Dealmakers

37 Target | 22 Bidder

£ 4.93 B

Value

25 Aug 2020|United States|Biotechnology
Cersci Therapeutics
Acadia Pharmaceuticals

Target: CERSCI THERAPEUTICS INC

Bidder: ACADIA PHARMACEUTICALS

9 Service Providers

3 Target | 3 Bidder | 3 Vendor

20 Dealmakers

10 Target | 7 Bidder | 3 Vendor

£ 717 M

Value

31 Aug 2020|United States|Biotechnology
Akcea Therapeutics
Ionis Pharmaceuticals

Target: AKCEA THERAPEUTICS

Bidder: IONIS PHARMACEUTICALS

10 Service Providers

4 Target | 6 Bidder

36 Dealmakers

9 Target | 27 Bidder

£ 334 M

Value

23 Sep 2020|China|Real Estate Holding and Development
Wework China
Trustbridge Partners

Target: WEWORK CHINA

Bidder: TRUSTBRIDGE PARTNERS

5 Service Providers

2 Target | 2 Bidder | 1 Vendor

14 Dealmakers

5 Target | 7 Bidder | 3 Vendor

£ 157 M

Value

12 Nov 2020|United States|Pharmaceuticals
Urovant Sciences
Sumitovant Biopharma

Target: UROVANT SCIENCES

Bidder: SUMITOVANT BIOPHARMA

8 Service Providers

5 Target | 3 Bidder

13 Dealmakers

11 Target | 3 Bidder

£ 144 M

Value

11 Dec 2020|United States|Machinery: Specialty
Boston Dynamics
Hyundai Motor Group

Target: BOSTON DYNAMICS

Bidder: HYUNDAI MOTOR GROUP

7 Service Providers

2 Target | 2 Bidder | 3 Vendor

34 Dealmakers

14 Target | 5 Bidder | 15 Vendor

£ 695 M

Value

11 Jan 2021|United States|Asset Managers and Custodians
National Holdings
B. Riley Financial

Target: NATIONAL HOLDINGS

Bidder: B. RILEY FINANCIAL INC

6 Service Providers

4 Target | 2 Bidder

24 Dealmakers

13 Target | 11 Bidder

n/a

Value

03 Feb 2021|United Kingdom|Pharmaceuticals
Gw Pharmaceuticals
Jazz Pharmaceuticals

Target: GW PHARMACEUTICALS PLC

Bidder: JAZZ PHARMACEUTICALS

20 Service Providers

7 Target | 13 Bidder

85 Dealmakers

33 Target | 52 Bidder

£ 5.27 B

Value

25 Feb 2021|United States|Biotechnology
Pandion Therapeutics
Merck & Co

Target: PANDION THERAPEUTICS INC

Bidder: MERCK & CO

7 Service Providers

4 Target | 3 Bidder

28 Dealmakers

16 Target | 12 Bidder

£ 1.31 B

Value

04 Mar 2021|United States|Biotechnology
Five Prime Therapeutics
Amgen

Target: FIVE PRIME THERAPEUTICS

Bidder: AMGEN INC

7 Service Providers

4 Target | 3 Bidder

34 Dealmakers

20 Target | 14 Bidder

£ 1.36 B

Value

26 Mar 2021|United States|Real Estate Holding and Development
Wework Companies
Bow Capital

Target: WEWORK COMPANIES INC

Bidder: BOW CAPITAL

17 Service Providers

4 Target | 11 Bidder | 2 Vendor

107 Dealmakers

25 Target | 70 Bidder | 13 Vendor

£ 6.53 B

Value

24 May 2021|United States|Pharmaceuticals
STRONGBRIDGE
Xeris Pharmaceuticals

Target: STRONGBRIDGE

Bidder: XERIS PHARMACEUTICALS

11 Service Providers

7 Target | 4 Bidder

53 Dealmakers

19 Target | 34 Bidder

£ 188 M

Value

02 Jun 2021|United States|Pharmaceuticals
Constellation Pharmaceuticals
Morphosys

Target: CONSTELLATION PHARMACEUTICALS

Bidder: MORPHOSYS AG

13 Service Providers

6 Target | 7 Bidder

58 Dealmakers

28 Target | 30 Bidder

£ 1.20 B

Value

03 Aug 2021|United States|Pharmaceuticals
Translate Bio
Sanofi

Target: TRANSLATE BIO

Bidder: SANOFI SA

12 Service Providers

7 Target | 3 Bidder | 2 Vendor

52 Dealmakers

17 Target | 34 Bidder | 1 Vendor

£ 2.30 B

Value

29 Sep 2021|United States|Biotechnology
Amicus Therapeutics (gene Therapy Business)
Arya Sciences Acquisition Corp Iv

Target: AMICUS THERAPEUTICS (GENE THERAPY BUSINESS)

Bidder: ARYA SCIENCES ACQUISITION CORP IV

9 Service Providers

4 Bidder | 5 Vendor

25 Dealmakers

10 Bidder | 15 Vendor

£ 440 M

Value

30 Sep 2021|United States|Biotechnology
Acceleron Pharma
Merck & Co

Target: ACCELERON PHARMA

Bidder: MERCK & CO

12 Service Providers

5 Target | 7 Bidder

81 Dealmakers

19 Target | 62 Bidder

£ 8.53 B

Value

11 Oct 2021|United States|Software
Aspen Technology
Emerson Electric Co

Target: ASPEN TECHNOLOGY INC

Bidder: EMERSON ELECTRIC CO

11 Service Providers

5 Target | 6 Bidder

49 Dealmakers

24 Target | 25 Bidder

£ 8.08 B

Value

18 Nov 2021|United States|Biotechnology
DICERNA
Novo Nordisk

Target: DICERNA

Bidder: NOVO NORDISK

8 Service Providers

5 Target | 3 Bidder

23 Dealmakers

13 Target | 10 Bidder

£ 2.45 B

Value

17 Dec 2021|United States|Payments / Commerce
BOTTOMLINE
Thoma Bravo

Target: BOTTOMLINE

Bidder: THOMA BRAVO LLC

10 Service Providers

5 Target | 5 Bidder

30 Dealmakers

18 Target | 12 Bidder

£ 1.96 B

Value

13 Apr 2022|Canada|Pharmaceuticals
Sierra Oncology
Glaxosmithkline

Target: SIERRA ONCOLOGY

Bidder: GLAXOSMITHKLINE PLC

7 Service Providers

4 Target | 3 Bidder

20 Dealmakers

5 Target | 15 Bidder

£ 1.52 B

Value

13 Apr 2022|United States|Pharmaceuticals
Antares Pharma
Halozyme

Target: ANTARES PHARMA

Bidder: HALOZYME INC

13 Service Providers

6 Target | 7 Bidder

59 Dealmakers

26 Target | 33 Bidder

£ 737 M

Value

10 May 2022|United States|Pharmaceuticals
Biohaven Pharmaceutical Holding Company
Pfizer

Target: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD

Bidder: PFIZER INC

11 Service Providers

5 Target | 6 Bidder

46 Dealmakers

23 Target | 23 Bidder

£ 9.42 B

Value

11 Jul 2022|United States|Biotechnology
VIACYTE
Vertex Pharmaceuticals

Target: VIACYTE

Bidder: VERTEX PHARMACEUTICALS INC

5 Service Providers

3 Target | 2 Bidder

42 Dealmakers

26 Target | 16 Bidder

£ 265 M

Value

22 Aug 2022|United States|Pharmaceuticals
Aerie Pharmaceuticals
Alcon

Target: AERIE PHARMACEUTICALS INC

Bidder: ALCON INC

9 Service Providers

5 Target | 4 Bidder

58 Dealmakers

33 Target | 25 Bidder

£ 650 M

Value

09 Jan 2023|United States|Biotechnology
Cincor Pharma
Astrazeneca

Target: CINCOR PHARMA

Bidder: ASTRAZENECA PLC

8 Service Providers

5 Target | 2 Bidder | 1 Vendor

79 Dealmakers

57 Target | 22 Bidder

£ 1.49 B

Value

13 Mar 2023|United States|Biotechnology
Seagen
Pfizer

Target: SEAGEN INC

Bidder: PFIZER INC

10 Service Providers

5 Target | 4 Bidder | 1 Vendor

67 Dealmakers

25 Target | 38 Bidder | 5 Vendor

£ 35.70 B

Value

16 Apr 2023|United States|Biotechnology
Prometheus Biosciences
Merck & Co

Target: PROMETHEUS BIOSCIENCES INC

Bidder: MERCK & CO

8 Service Providers

5 Target | 3 Bidder

50 Dealmakers

31 Target | 19 Bidder

£ 8.70 B

Value

18 Apr 2023|Canada|Biotechnology
Bellus Health
Glaxosmithkline

Target: BELLUS HEALTH

Bidder: GLAXOSMITHKLINE PLC

8 Service Providers

4 Target | 4 Bidder

17 Dealmakers

14 Target | 3 Bidder

£ 1.61 B

Value

30 Apr 2023|United States|Biotechnology
Iveric Bio
Astellas Pharma

Target: IVERIC BIO

Bidder: ASTELLAS PHARMA INC

9 Service Providers

6 Target | 3 Bidder

22 Dealmakers

17 Target | 5 Bidder

£ 4.69 B

Value

10 May 2023|United States|Pharmaceuticals
Cti Biopharma
Swedish Orphan Biovitrum (sobi)

Target: CTI BIOPHARMA

Bidder: SWEDISH ORPHAN BIOVITRUM AB (SOBI)

16 Service Providers

7 Target | 9 Bidder

76 Dealmakers

26 Target | 51 Bidder

£ 1.35 B

Value

26 Sep 2023|United States|Biotechnology
Intercept Pharmaceuticals
Alfasigma

Target: INTERCEPT PHARMACEUTICALS

Bidder: ALFASIGMA SPA

11 Service Providers

5 Target | 6 Bidder

31 Dealmakers

22 Target | 9 Bidder

£ 649 M

Value

03 Oct 2023|United States|Biotechnology
Point Biopharma
Eli Lilly And Company

Target: POINT BIOPHARMA

Bidder: ELI LILLY AND COMPANY

7 Service Providers

3 Target | 4 Bidder

40 Dealmakers

16 Target | 24 Bidder

£ 1.15 B

Value

08 Oct 2023|United States|Biotechnology
Mirati Therapeutics
Bristol Myers Squibb Company

Target: MIRATI THERAPEUTICS

Bidder: BRISTOL MYERS SQUIBB COMPANY

14 Service Providers

5 Target | 9 Bidder

54 Dealmakers

23 Target | 31 Bidder

£ 3.84 B

Value

23 Oct 2023|United States|Software
ENGAGESMART
Vista Equity Partners

Target: ENGAGESMART

Bidder: VISTA EQUITY PARTNERS

11 Service Providers

5 Target | 4 Bidder | 2 Vendor

48 Dealmakers

25 Target | 19 Bidder | 4 Vendor

£ 3.29 B

Value

06 Dec 2023|United States|Pharmaceuticals
Cerevel Therapeutics
Abbvie

Target: CEREVEL THERAPEUTICS

Bidder: ABBVIE INC

10 Service Providers

5 Target | 5 Bidder

57 Dealmakers

33 Target | 24 Bidder

£ 6.89 B

Value

08 Jan 2024|United States|Biotechnology
Ambrx
Johnson & Johnson

Target: AMBRX INC

Bidder: JOHNSON & JOHNSON

9 Service Providers

6 Target | 3 Bidder

41 Dealmakers

22 Target | 19 Bidder

£ 1.49 B

Value

05 Feb 2024|Germany|Biotechnology
Morphosys
Novartis

Target: MORPHOSYS AG

Bidder: NOVARTIS AG

9 Service Providers

5 Target | 4 Bidder

103 Dealmakers

31 Target | 74 Bidder

£ 2.31 B

Value

12 Feb 2024|United States|Pharmaceuticals
Cymabay Therapeutics
Gilead Sciences

Target: CYMABAY THERAPEUTICS

Bidder: GILEAD SCIENCES

11 Service Providers

6 Target | 5 Bidder

37 Dealmakers

18 Target | 19 Bidder

£ 3.40 B

Value

10 Apr 2024|United States|Biotechnology
Alpine Immune Sciences
Vertex Pharmaceuticals

Target: ALPINE IMMUNE SCIENCES INC

Bidder: VERTEX PHARMACEUTICALS INC

8 Service Providers

4 Target | 4 Bidder

58 Dealmakers

37 Target | 21 Bidder

£ 3.87 B

Value

23 Jan 2024|United States|Biotechnology
INHIBRX
Sanofi

Target: INHIBRX

Bidder: SANOFI SA

9 Service Providers

4 Target | 5 Bidder

62 Dealmakers

9 Target | 53 Bidder

£ 1.34 B

Value

29 May 2024|United States|Biotechnology
EYEBIOTECH
Merck & Co

Target: EYEBIOTECH

Bidder: MERCK & CO

8 Service Providers

3 Target | 4 Bidder | 1 Vendor

26 Dealmakers

18 Target | 7 Bidder | 1 Vendor

£ 2.35 B

Value

18 Apr 2024|United States|Biotechnology
23andme
Anne Wojcicki

Target: 23ANDME INC

Bidder: ANNE WOJCICKI

5 Service Providers

4 Target | 1 Bidder

10 Dealmakers

8 Target | 2 Bidder

n/a

Value

01 Aug 2024|United States|Business Process Outsourcing
R1 Rcm
Towerbrook Capital Partners

Target: R1 RCM

Bidder: TOWERBROOK CAPITAL PARTNERS LP

26 Service Providers

7 Target | 17 Bidder | 2 Vendor

98 Dealmakers

34 Target | 64 Bidder | 2 Vendor

£ 6.93 B

Value

08 Aug 2024|United States|Biotechnology
G1 Therapeutics
Pharmacosmos Therapeutics

Target: G1 THERAPEUTICS

Bidder: PHARMACOSMOS THERAPEUTICS

8 Service Providers

5 Target | 3 Bidder

15 Dealmakers

13 Target | 2 Bidder

£ 318 M

Value

05 Nov 2024|United States|Software
Aspen Technology
Emerson Electric Co

Target: ASPEN TECHNOLOGY INC

Bidder: EMERSON ELECTRIC CO

12 Service Providers

6 Target | 6 Bidder

55 Dealmakers

27 Target | 28 Bidder

£ 5.55 B

Value

10 Jan 2025|United States|Biotechnology
Akoya Biosciences
QUANTERIX

Target: AKOYA BIOSCIENCES

Bidder: QUANTERIX

11 Service Providers

4 Target | 7 Bidder

27 Dealmakers

1 Target | 26 Bidder

n/a

Value

13 Jan 2025|United States|Pharmaceuticals
Intra-cellular Therapies
Johnson & Johnson

Target: INTRA-CELLULAR THERAPIES INC

Bidder: JOHNSON & JOHNSON

8 Service Providers

5 Target | 3 Bidder

33 Dealmakers

19 Target | 14 Bidder

£ 11.96 B

Value

24 Jan 2025|United States|Software
Logility
Aptean

Target: LOGILITY INC

Bidder: APTEAN INC

7 Service Providers

4 Target | 3 Bidder

10 Dealmakers

6 Target | 4 Bidder

£ 387 M

Value

28 Jan 2025|United Kingdom|Pharmaceuticals
Evergreen Theragnostics
LANTHEUS

Target: EVERGREEN THERAGNOSTICS

Bidder: LANTHEUS

11 Service Providers

5 Target | 6 Bidder

64 Dealmakers

13 Target | 51 Bidder

£ 200 M

Value

05 Mar 2025|United States|Pharmaceuticals
CHIMERIX
Jazz Pharmaceuticals

Target: CHIMERIX

Bidder: JAZZ PHARMACEUTICALS

10 Service Providers

6 Target | 4 Bidder

53 Dealmakers

31 Target | 22 Bidder

£ 734 M

Value

06 Mar 2025|United States|Diversified Retailers
Shields Health
Sycamore Partners

Target: SHIELDS HEALTH

Bidder: SYCAMORE PARTNERS LP

22 Service Providers

11 Target | 10 Bidder | 1 Vendor

128 Dealmakers

91 Target | 31 Bidder | 6 Vendor

£ 18.39 B

Value

28 Apr 2025|United States|Biotechnology
Springworks Therapeutics
Merck Kgaa

Target: SPRINGWORKS THERAPEUTICS

Bidder: MERCK KGAA

8 Service Providers

5 Target | 3 Bidder

69 Dealmakers

42 Target | 27 Bidder

£ 2.55 B

Value

16 May 2025|United States|Biotechnology
Inozyme Pharma
Biomarin Pharmaceutical

Target: INOZYME PHARMA

Bidder: BIOMARIN PHARMACEUTICAL

8 Service Providers

5 Target | 3 Bidder

39 Dealmakers

21 Target | 18 Bidder

£ 203 M

Value

27 May 2025|United States|Pharmaceuticals
Siteone Therapeutics
Eli Lilly And Company

Target: SITEONE THERAPEUTICS INC

Bidder: ELI LILLY AND COMPANY

7 Service Providers

4 Target | 3 Bidder

16 Dealmakers

12 Target | 4 Bidder

£ 737 M

Value

16 Jun 2025|United States|Pharmaceuticals
Sage Therapeutics
Supernus Pharmaceuticals

Target: SAGE THERAPEUTICS

Bidder: SUPERNUS PHARMACEUTICALS

9 Service Providers

5 Target | 4 Bidder

26 Dealmakers

16 Target | 10 Bidder

£ 585 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Graham Robinson